Condition
Neoplasms, Prostate clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Neoplasms, Prostate clinical trials that are recruiting, at sites in 8 countries (most in United States (6), Canada (3), Japan (3)). By phase: Phase 1/2 (2), Phase 3 (1), Phase 1 (1). The most active sponsors are GlaxoSmithKline (3), Urological Research Network, LLC (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 8Countries
Newest Neoplasms, Prostate clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Lifestyle-fit test for risvutatug rezetecan in advanced prostate cancer | Phase 3 | Auchenflower, Queensland and 5 other locations | Recruiting | Sep 3, 2026 |
| FX-111 safety and pharmacokinetics in metastatic castration-resistant prostate cancer | Phase 1 | Los Angeles, California and 9 other locations | Recruiting | Jul 22, 2026 |
| Testing GSK5471713 in adults with metastatic castration-resistant prostate cancer | Phase 1/2 | La Jolla, California and 19 other locations | Recruiting | Jan 12, 2026 |
| Using AI to help find prostate cancer on MRI | — | Cleveland, Ohio | Recruiting | Jul 25, 2025 |
| GSK5458514 alone or with other anti-cancer drugs for prostate cancer | Phase 1/2 | Phoenix, Arizona and 19 other locations | Recruiting | May 25, 2025 |
| Laser ablation treatment for prostate cancer using MRI and ultrasound guidance | — | Miami Lakes, Florida | Recruiting | Feb 15, 2022 |
| MRI and Ultrasound Guided Cryotherapy for Prostate Cancer | — | Miami Lakes, Florida | Recruiting | Mar 6, 2015 |
All recruiting trials (7)
-
Lifestyle-fit test for risvutatug rezetecan in advanced prostate cancer
This study tests whether risvutatug rezetecan can help men with metastatic castration-resistant prostate cancer live longer or feel better compared with standard care.
-
FX-111 safety and pharmacokinetics in metastatic castration-resistant prostate cancer
This study tests whether FX-111 is safe and can help treat metastatic castration-resistant prostate cancer in adult men.
-
Testing GSK5471713 in adults with metastatic castration-resistant prostate cancer
This trial will test whether the experimental drug GSK5471713 is safe, tolerable, and shows early signs of benefit in adults with metastatic castration-resistant prostate cancer who have progressed on androgen-deprivation therapy and prior AR pathway inhibitors.
-
Using AI to help find prostate cancer on MRI
This study tests whether an AI software can help doctors find suspicious lesions on prostate MRI in men aged 55–80 who are having a pre-biopsy MRI and planned prostate biopsy.
-
GSK5458514 alone or with other anti-cancer drugs for prostate cancer
This trial will test the safety and how the body handles GSK5458514 alone or combined with other cancer medicines in adult men with metastatic castration-resistant prostate cancer.
-
Laser ablation treatment for prostate cancer using MRI and ultrasound guidance
This study is testing how well a new laser treatment for prostate cancer works when guided by MRI and ultrasound, while also looking at how it affects patients' urinary and sexual function over time.
-
MRI and Ultrasound Guided Cryotherapy for Prostate Cancer
This study is testing if using MRI and ultrasound to guide cryotherapy can help men with prostate cancer get rid of their tumors while keeping side effects low and improving their quality of life.
Related topics
Quick answers
How many Neoplasms, Prostate clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (6 trials), Canada (3 trials), Japan (3 trials), Australia (2 trials), South Korea (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.